Foresite Capital Management V, LLC
In its 13F for Q2 2025 (holdings as of June 30, 2025, filed August 12, 2025), Foresite Capital Management V, LLC reported 6 stock positions worth $80.7 million. Its top holding was CG Oncology (CGON) at 32.3% of the portfolio, followed by Alumis (ALMS, 21.5%) and Disc Medicine (IRON, 19.6%). Compared with Q1 2025, it added to 1. The biggest buy was CG Oncology (CGON, shares +17%).
- Most Recent 13F
- Q2 2026
- Location
- WEST HOLLYWOOD, CA
- CIK
- 0001792206
- Portfolio Value
- $80.7M (Q2 2025)
- SEC Filing
- 0001104659-25-076820 ↗ filed Aug 12, 2025
Holdings Value
Holdings 6 stocks · $80.7M
| CGON CG Oncology Inc. | 32.34% | 1,004,050 | $26.1M | Add +16.9% |
| ALMS Alumis Inc. | 21.48% | 5,779,348 | $17.3M | No change |
| IRON Disc Medicine Inc. | 19.62% | 299,069 | $15.8M | No change |
| HIMS Hims & Hers Health Inc. | 16.87% | 273,151 | $13.6M | No change |
| MAZE Maze Therapeutics Inc. | 5.25% | 345,191 | $4.2M | No change |
| LYEL Lyell Immunopharma Inc. | 4.45% | 406,652 | $3.6M | No change |
Portfolio Sells Q1 2025 → Q2 2025
| None this quarter. | |||
Portfolio Buys Q1 2025 → Q2 2025
| CGON CG Oncology Inc. | Add +16.9% | 32.34% | +8.33 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 9 | $362.2M | ALMS, CGON, IRON, HIMS, PHVS |
| Q1 2026 | 9 | $271.0M | ALMS, CGON, IRON, HIMS, EIKN |
| Q4 2025 | 7 | $164.4M | ALMS, CGON, IRON, NTRA, LYEL |
| Q3 2025 | 6 | $108.7M | CGON, ALMS, IRON, HIMS, LYEL |
| Q2 2025 | 6 | $80.7M | CGON, ALMS, IRON, HIMS, MAZE |
| Q1 2025 | 6 | $87.6M | ALMS, CGON, IRON, HIMS, LYEL |
| Q4 2024 | 6 | $120.2M | ALMS, HIMS, CGON, IRON, CGEM |
| Q3 2024 | 5 | $143.9M | ALMS, HIMS, CGON, IRON, CGEM |
| Q2 2024 | 5 | $156.6M | ALMS, HIMS, CGON, IRON, CGEM |
| Q1 2024 | 5 | $106.5M | HIMS, CGON, IRON, KNTE, 23ANDME HOLDING CO |